Monopar Therapeutics stock resistance test: Key levels to watch

Monopar Therapeutics stock resistance test: Key levels to watch
Monopar Therapeutics gains 3.17% today

Monopar Therapeutics (MNPR) stock is trading at $114.33, up 3.17% on the day and closing near the session’s high. The move lifts the stock above its key moving averages, marking relative strength on both short- and long-term timeframes.

MNPR price prediction
24H 1.21%
$72.9425
48H 3.52%
$74.61
7D 3.49%
$74.5825
1M 1.67%
$73.27
3M -20.38%
$57.3838
6M -32.96%
$48.3126
12M -5.94%
$67.7895
Current price: $72.07 -0.6100 0.84%
Closed 11/13
Daily range 68.6600 Arrow from to Icon 73.6350
Weekly range 67.2200 Arrow from to Icon 75.2600
Loading...

Highlights

  • MNPR/USD is trading above key short-, medium-, and long-term moving averages, indicating trend strength across all timeframes.
  • Momentum indicators give mixed signals with most showing weak or negative momentum and limited buying pressure.
  • Expected trading range for the next 2 to 3 days is $106.2315 to $122.4385, with support at $111.615 and resistance at $122.44.

Mixed momentum as price holds above technical supports

On the technical side, MNPR is trading above the MA-20, MA-50, and MA-200, with the daily Ichimoku Kijun line at $111.61 marking immediate support. Short-term resistance stands at $122.44, while the next key support sits at $106.23. Among momentum indicators, MACD and Awesome Oscillator are both signaling strong sell, ADX and CCI are neutral, the RSI prints 42.3, and Stoch RSI generates additional sell signals. Bull/Bear Power remains oversold, highlighting recent dominance by sellers, despite high intraday volatility and an up-close.

Monopar Therapeutics asset chart
Monopar Therapeutics price dynamics. Source: TradingView.

Range-bound outlook as breakout odds remain balanced

Over the next 2–3 trading days, price is likely to consolidate within a volatility band of $106.23 to $122.44. The probability of an upward breakout is only slightly higher at 52%, with a downside reversal still possible at 48%. A close above $122.44 would signal the start of a bullish leg, while a breakdown below $111.61 could expose $106.23 as the next downside target.

Viktoras Karapetjanc, expert at Traders Union, sees MNPR’s strong technical setup as a positive sign, even in the absence of news drivers. He believes the stock’s ability to hold above key moving averages shows underlying strength and potential market confidence. Volatility remains high, but with support at $111.61 and resistance at $122.44, the risk-reward appears constructive for cautious bulls. "If MNPR can close above $122.44, I expect buyers to take control and push the next bullish phase."

Earlier, analysts noted that Monopar Therapeutics was experiencing short-term selling pressure despite maintaining longer-term technical strength. The latest action signals technical stabilization above key moving averages, with $122.44 emerging as the pivotal resistance level traders should monitor for confirmation of renewed upside momentum.

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.